Literature DB >> 2445266

Acute illness in Nigerian children with sickle cell anaemia.

O Akinyanju1, A O Johnson.   

Abstract

The pattern of illness in 60 consecutive children with homozygous sickle cell disease who attended the Paediatric Emergency Room of a busy Lagos hospital with acute illness was studied prospectively. Their ages ranged from 3 months to 13 years with a peak in the 2nd year. There were twice as many boys as girls. The commonest symptoms were fever, limb or abdominal pain and cough, and the commonest signs were pallor and hepatomegaly. Painful crises occurred in 27, anaemic crises in 11, and a combination of these in 12 children. Infection was detected in 76% of subjects in crises. Infection was found in 82% of all the children and was mainly bacterial. The commonest infections were pneumonia (35%), bacteraemia (32%), tonsillitis/pharyngitis (17%) and osteomyelitis (8%). The predominant bacteria isolated were Klebsiella spp (38%), E. coli (23%), Staph. aureus (23%), Staph. albus (23%) and Pseudomonas spp (23%). Some children had multiple isolates. Bacterial infection was a major cause of morbidity in very young children and merits appropriate control and preventive measures in this age group. The spectrum of bacteria isolated makes it unlikely that the specific anti-pneumococcal measures widely advocated in Europe and America for young children with SCA would be appropriate in Nigeria.

Entities:  

Mesh:

Year:  1987        PMID: 2445266     DOI: 10.1080/02724936.1987.11748503

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  14 in total

1.  Mortality from sickle cell disease in Africa.

Authors:  Graham R Serjeant
Journal:  BMJ       Date:  2005-02-26

2.  Current sickle cell disease management practices in Nigeria.

Authors:  N Galadanci; B J Wudil; T M Balogun; G O Ogunrinde; A Akinsulie; F Hasan-Hanga; A S Mohammed; M O Kehinde; J A Olaniyi; I N Diaku-Akinwumi; B J Brown; S Adeleke; O E Nnodu; I Emodi; S Ahmed; A O Osegbue; N Akinola; H I O Opara; S A Adegoke; J Aneke; A D Adekile
Journal:  Int Health       Date:  2013-10-10       Impact factor: 2.473

Review 3.  Sickle cell disease in Africa: burden and research priorities.

Authors:  J Makani; T N Williams; K Marsh
Journal:  Ann Trop Med Parasitol       Date:  2007-01

4.  The rate and cost of hospitalisation in children with sickle cell anaemia and its implications in a developing economy.

Authors:  Samuel A Adegoke; Emmanuel A Abioye-Kuteyi; Ernest O Orji
Journal:  Afr Health Sci       Date:  2014-06       Impact factor: 0.927

5.  Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?

Authors:  M E Kizito; E Mworozi; C Ndugwa; G R Serjeant
Journal:  Arch Dis Child       Date:  2006-03-10       Impact factor: 3.791

6.  Types of anaemic crises in paediatric patients with sickle cell anaemia seen in Enugu, Nigeria.

Authors:  A I Juwah; E U Nlemadim; W Kaine
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

Review 7.  Travelers with sickle cell disease.

Authors:  Shaina M Willen; Courtney D Thornburg; Paul M Lantos
Journal:  J Travel Med       Date:  2014-06-19       Impact factor: 8.490

Review 8.  Sickle Cell Disease in Sub-Saharan Africa.

Authors:  Thomas N Williams
Journal:  Hematol Oncol Clin North Am       Date:  2016-01-28       Impact factor: 3.722

9.  Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study.

Authors:  Thomas N Williams; Sophie Uyoga; Alex Macharia; Carolyne Ndila; Charlotte F McAuley; Daniel H Opi; Salim Mwarumba; Julie Makani; Albert Komba; Moses N Ndiritu; Shahnaaz K Sharif; Kevin Marsh; James A Berkley; J Anthony G Scott
Journal:  Lancet       Date:  2009-09-09       Impact factor: 79.321

10.  Relationship between antibiotic resistance and sickle cell anemia: preliminary evidence from a pediatric carriage study in Ghana.

Authors:  Eric S Donkor; Ebenezer Foster-Nyarko; Christabel C Enweronu-Laryea
Journal:  Infect Drug Resist       Date:  2013-07-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.